Bellon Christine sold BEAM
January 22, 2026 · Form 4 insider transaction
Bellon Christine sold 1,371 shares of Beam Therapeutics Inc. at $34.00 per share, a transaction worth $46.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,371
Price
$34.00
Total value
$46.6K
InsiderBellon Christine
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 22, 2026
Filing dateJanuary 26, 2026
Shares owned after95,667
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2025.